Alexey L. Margolin, Chief Scientific Officer at Altus Pharmaceuticals Inc. (ALTU), sold 6,250 shares at $18.73 ($117K) on 2007-01-22, disclosed to the SEC on 2007-01-22.
Scheduled sale ($117k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ALTU | SELL | 2007-03-26 | $50K | — | Filing → |
| ALTU | SELL | 2007-03-19 | $47K | — | Filing → |
| ALTU | SELL | 2007-03-06 | $44K | — | Filing → |